Loading...
Alphatec Holdings, Inc.
ATEC•NASDAQ
Healthcare
Medical - Devices
$10.82
$0.11(1.03%)
Alphatec Holdings, Inc. (ATEC) Financial Performance & Income Statement Overview
Review Alphatec Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
26.81%
↑ 26.81%
Operating Income Growth
21.47%
↑ 21.47%
Net Income Growth
13.14%
↑ 13.14%
Operating Cash Flow Growth
43.11%
↑ 43.11%
Operating Margin
-20.53%
↓ 20.53%
Gross Margin
65.87%
↑ 65.87%
Net Profit Margin
-25.77%
↓ 25.77%
ROE
-257.63%
↓ 257.63%
ROIC
-21.01%
↓ 21.01%
Alphatec Holdings, Inc. (ATEC) Income Statement & Financial Overview
Review Alphatec Holdings, Inc.'s (ATEC) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $116.00M | $176.79M | $150.72M | $145.57M |
| Cost of Revenue | $0.00 | $55.20M | $47.99M | $62.86M |
| Gross Profit | $116.00M | $121.59M | $102.73M | $82.72M |
| Gross Profit Ratio | $1.00 | $0.69 | $0.68 | $0.57 |
| R&D Expenses | $16.58M | $23.24M | $20.36M | $19.11M |
| SG&A Expenses | $127.02M | $114.54M | $109.20M | $96.69M |
| Operating Expenses | $160.29M | $145.41M | $136.43M | $115.80M |
| Total Costs & Expenses | $160.29M | $200.61M | $181.40M | $178.65M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$7.84M | $7.15M | $6.57M | $5.82M |
| Depreciation & Amortization | $15.46M | $20.82M | $21.92M | $21.07M |
| EBITDA | -$44.29M | -$4.33M | -$11.16M | -$14.08M |
| EBITDA Ratio | -$0.38 | -$0.02 | -$0.07 | -$0.10 |
| Operating Income | -$44.29M | -$23.82M | -$30.68M | -$33.08M |
| Operating Income Ratio | -$0.38 | -$0.13 | -$0.20 | -$0.23 |
| Other Income/Expenses (Net) | -$7.62M | -$9.07M | -$8.98M | -$5.66M |
| Income Before Tax | -$51.91M | -$32.89M | -$39.65M | -$40.97M |
| Income Before Tax Ratio | -$0.45 | -$0.19 | -$0.26 | -$0.28 |
| Income Tax Expense | $0.00 | $441000.00 | -$36000.00 | -$286000.00 |
| Net Income | -$51.91M | -$33.33M | -$39.62M | -$40.68M |
| Net Income Ratio | -$0.45 | -$0.19 | -$0.26 | -$0.28 |
| EPS | -$0.35 | -$0.23 | -$0.28 | -$0.29 |
| Diluted EPS | -$0.35 | -$0.23 | -$0.28 | -$0.29 |
| Weighted Avg Shares Outstanding | $146.73M | $142.95M | $143.49M | $142.69M |
| Weighted Avg Shares Outstanding (Diluted) | $146.73M | $142.95M | $143.49M | $142.69M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan